Paul V. Maier's most recent trade in Eton Pharmaceuticals Inc was a trade of 25,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eton Pharmaceuticals Inc | Paul Victor Maier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (Right to Buy) | |
| Eton Pharmaceuticals Inc | Paul Maier Victor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2024 | 30,000 | 164,555 | - | - | Stock Option (Right to buy) | |
| Eton Pharmaceuticals Inc | Paul Victor Maier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 25,000 | 134,555 | - | - | Stock Option(Right to buy) | |
| Eton Pharmaceuticals Inc | Paul Victor Maier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2022 | 50,000 | 109,555 | - | - | Stock Option(Right to buy) | |
| Eton Pharmaceuticals Inc | Paul Victor Maier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2021 | 19,655 | 59,555 | - | - | Stock Option(Right to buy) |